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Abstract 
Background: Health inequality is a recognized barrier to achieving health‑related development goals. Health‑equal‑
ity data are essential for evidence‑based planning and assessing the effectiveness of initiatives to promote equity. 
Such data have been captured but have not always been analysed or used to manage programming. Health data 
were examined for microeconomic differences in malaria indices and associated malaria control initiatives in western 
Kenya.
Methods: Data was analysed from a malaria cross‑sectional survey conducted in July 2012 among 2719 people in 
1063 households in Siaya County, Kenya. Demographic factors, history of fever, malaria parasitaemia, malaria medica‑
tion usage, insecticide‑treated net (ITN) use and expenditure on malaria medications were collected. A composite 
socioeconomic status score was created using multiple correspondence analyses (MCA) of household assets; house‑
holds were classified into wealth quintiles and dichotomized into poorest (lowest 3 quintiles; 60%) or less‑poor (high‑
est 2 quintiles; 40%). Prevalence rates were calculated using generalized linear modelling.
Results: Overall prevalence of malaria infection was 34.1%, with significantly higher prevalence in the poorest 
compared to less‑poor households (37.5% versus 29.2%, adjusted prevalence ratio [aPR] 1.23; 95% CI = 1.08–1.41, 
p = 0.002). Care seeking (aPR = 0.95; 95% CI 0.87–1.04, p = 0.229), medication use (aPR = 0.94; 95% CI 0.87–1.00, 
p = 0.087) and ITN use (aPR = 0.96; 95% CI = 0.87–1.05, p = 0.397) were similar between households. Among all 
persons surveyed, 36.4% reported taking malaria medicines in the prior 2 weeks; 92% took artemether‑lumefantrine, 
the recommended first‑line malaria medication. In the poorest households, 4.9% used non‑recommended medi‑
cines compared to 3.5% in less‑poor (p = 0.332). Mean and standard deviation [SD] for expenditure on all malaria 
medications per person was US$0.38 [US$0.50]; the mean was US$0.35 [US$0.52] amongst the poorest households 
and US$0.40 [US$0.55] in less‑poor households (p = 0.076). Expenditure on non‑recommended malaria medicine 
was significantly higher in the poorest (mean US$1.36 [US$0.91]) compared to less‑poor households (mean US$0.98 
[US$0.80]; p = 0.039).
Conclusions: Inequalities in malaria infection and expenditures on potentially ineffective malaria medication 
between the poorest and less‑poor households were evident in rural western Kenya. Findings highlight the benefits 
of using MCA to assess and monitor the health‑equity impact of malaria prevention and control efforts at the micro‑
economic level.
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Background
Malaria is one of the most important diseases in many 
low- and middle-income countries, primarily affecting 
children and pregnant women in sub-Saharan Africa. In 
1999, approximately 60% of global malaria deaths were 
concentrated among the poorest 20% of the global pop-
ulation [1]. In sub-Saharan Africa, 3.1% of all disability-
adjusted life-years (DALYs) were lost to malaria in 2002 
[2]. Although preventable and treatable, the number of 
deaths due to malaria remains high. In 2015, there were 
an estimated 429,000 malaria deaths (range 235,000–
639,000) worldwide, and most (92%) of these deaths 
occurred in the Africa [3]. In Kenya, despite remarkable 
achievements in malaria prevention and control over the 
last 10 years, malaria remains a leading cause of morbid-
ity and mortality [4]. In 2015, while the prevalence of 
microscopically-confirmed malaria was 8% amongst chil-
dren less than 15 years (13% by malaria rapid diagnostic 
test [RDT]) nationally, it was 27% (43% by malaria RDT) 
in the lake-endemic region of western Kenya [5].
The relationship between malaria disease and poverty 
has often been described as a vicious cycle and whether 
malaria infection is a consequence of or a cause for low 
household socioeconomic status (SES) has been debated 
for decades [6]. In a systematic review of nine stud-
ies to establish the relationship between malaria and 
poverty, two studies found a significant relationship 
between poverty and malaria, four studies found no sig-
nificant relationship and three studies demonstrated 
mixed results [7]. Malaria also imposes substantial costs 
to individuals, households and governments. Globally 
in 2015, total funding for malaria control and elimina-
tion efforts was estimated at US$2.9 billion; governments 
in malaria-endemic countries provided 32% of the total 
funding, of which 65% or US$612 million was expendi-
ture by national malaria control programmes for pro-
gramme implementation and 35% or US$332 million 
was expenditure on health service delivery [3]. In high 
malaria-transmission settings in Kenya where the average 
annual household expenditure was less than US$800 [8], 
households spent an average of US$10 (range US$9–12) 
monthly and approximately US$120 (range US$108–144) 
annually on malaria treatment in 2010 [9].
The microeconomic relationship between malaria bur-
den and composite wealth indices is also mixed and con-
tradictory [7]. A study among Tanzanian children, using 
principal component analysis (PCA) to rank households, 
established that malaria was associated with household 
SES when SES was the dependent variable, but an indi-
vidual’s SES was not associated with malaria risk when 
malaria was the dependent variable [6]. Another study in 
Tanzania, which investigated causality between malaria 
and SES, established that the higher the household wealth 
quintile the lower the prevalence of malaria in individuals 
in the household [10]. The lack of consistent findings may 
partly reflect the inherent difficulty in measuring SES and 
differences in the populations studied, methods used to 
measure malaria infection and malaria intensity in the 
study areas [7, 11–13].
Various methodologies for assessing SES employing 
broad quantitative and qualitative aspects of poverty 
have been recommended including PCA, polychoric 
PCA and multiple component analysis (MCA) [14–19]. 
A study from rural western Kenya compared the three 
methods of ranking households into SES quintiles and 
established that although the methods produced simi-
lar results, MCA gave the highest percentage of the total 
variation for the household asset variables and thus the 
largest weights for the variables. The study concluded 
that MCA was a better model for generating asset 
weights than PCA or polychoric PCA [20]. The study 
further conducted comparison between ordinary PCA 
and MCA and established that 93% of households were 
placed in the same quintile by both methods, 87% of the 
households by ordinary PCA and Polychoric, and 91% by 
Polychoric and MCA and that ordinary PCA asset index 
was statistically significantly correlated with the index 
based on MCA (r = 0.997, p < 0.01) [20]. The MCA model 
also allows both quantitative and qualitative variables, 
which is not possible with traditional PCA methods [20–
22]. However, studies using MCA methods to investigate 
socioeconomic inequalities related to malaria indicators 
are lacking.
Health inequality data, including malaria parasitae-
mia prevalence, use of malaria prevention and treatment 
interventions and expenditures on malaria medication, 
are often collected but not analysed from an economic 
or equity perspective. Yet, such data and analysis are 
important for monitoring health inequalities and the 
impact of malaria control interventions at the micro-
economic level. The aim of this study was to establish 
the relationship between household SES and inequalities 
in malaria-related health indicators including morbid-
ity, use of insecticide-treated nets (ITNs), care seeking, 
and expenditure on malaria medications in a malaria-
endemic area of rural western Kenya.
Methods
Study site
A community-based cross-sectional survey was con-
ducted in mid-2012, a year after a mass ITN distribution 
in Siaya County. The survey was conducted within the 
Kenya Medical Research Institute (KEMRI) and Cent-
ers for Disease Control and Prevention (CDC) health 
and demographic surveillance system (HDSS) in Siaya 
County, western Kenya. The HDSS has been described in 
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detail elsewhere [20, 23–25]. Briefly, the HDSS area cov-
ers a population of approximately 223,000 people resid-
ing in 393 villages in three sub-counties of Siaya County, 
spread over approximately 700  km2 along the shores of 
Lake Victoria. The vast majority of the population earn 
their living through subsistence farming and fishing. 
Residents of the HDSS were visited in their homes every 
4  months to record births, deaths, pregnancies, immi-
gration and out-migration. Health indicators in Siaya 
County, formerly part of Nyanza Province, are poor com-
pared to the national averages [26, 27]. Nyanza Province 
had the highest rate of child mortality at 72 deaths per 
1000 live births in 2008–2009, and an estimated 60% of 
the population lived below poverty line during the study 
period [26, 27].
Population, sampling strategy and sample size
The sampling frame obtained from the HDSS included all 
households with children < 5  years of age because many 
malaria interventions target this age group. Households 
were selected for participation by systematic random 
sampling, stratified by sub-county (i.e., Rarieda, Gem or 
Siaya). The sampling interval was calculated by dividing 
the total number of selected compounds by the target 
sample size. A random start number was selected from 
the ordered compound listing. Households were selected 
based on systematically adding the sampling interval to 
the random start number until the required sample size 
had been achieved. In total, 998 compounds compris-
ing 1063 households were sampled. A sub-sample of 
all household members were surveyed (5–14  years and 
15 + years), except for children < 5  years, who for ethi-
cal reasons were all included. If an individual of any age 
group (< 5 years, 5–14 years and ≥ 15 years) was sampled 
in a household, then all children < 5 in that household 
were also included in the survey.
Data collection
Study participants were interviewed face-to-face by 
trained field staff using a structured questionnaire, pro-
grammed into a personal digital assistant, to collect data 
on demographic factors, socioeconomic factors includ-
ing asset ownership and utilities, ITN ownership and 
usage night before the survey, history of fever in the past 
14  days, care-seeking behaviours and medication use 
in the past 14  days. A finger prick blood specimen was 
obtained from all individuals in the sampled households; 
haemoglobin was measured by  HemoCue® (Ängelholm, 
Sweden) and the presence of malaria parasitaemia was 
evaluated using RDT (Carestart™ Malaria HRP-2/pLDH 
(Pf/PAN) Combo, Somerset, NJ, USA). Individuals with 
a positive malaria RDT were treated in accordance with 
the 2010 Kenya national malaria treatment guidelines 
for uncomplicated malaria while complicated cases were 
referred to nearby health facilities for treatment [28]. 
Additionally, thick and thin blood smears were taken for 
screening, malaria species’ identification and enumera-
tion of parasite density.
Medication prices used to estimate expenditures were 
obtained from a separate survey in the same area, which 
assessed the availability and cost of antimalarial medi-
cations in September 2013 [29]. Medication prices were 
estimated using the local prices in Kenya shillings and 
converted to US dollars using the October 2013 exchange 
rate of 85 Kenya shillings to US$1.00 [29]. Non-recom-
mended medications for uncomplicated malaria included 
amodiaquine, chloroquine, sulfadoxine-pyrimethamine, 
and quinine (not recommended for use by non-pregnant 
women). In Kenya, quinine is only recommended as a 
first-line malaria medication for women in the first tri-
mester of pregnancy [28]. The variables used to generate 
household SES index included the occupation of house-
hold head (which included; doing business, commer-
cial, farming, housewife, salaried worker, skilled labour, 
unskilled labour and subsistence farming) primary source 
of drinking water, type of cooking fuel, ownership of 
household assets (e.g., lantern lamp, radio, television, 
bicycle) and ownership of livestock (e.g., cattle, chicken, 
pigs, donkey) [20].
Data management and analysis
Data were downloaded into a Microsoft Access (Version 
2010, Microsoft, and Seattle, WA, USA) database for 
management. Laboratory analyses of microscopy results 
were recorded in an Excel (Version 2010, Microsoft, Seat-
tle, WA, USA) spreadsheet. All the datasets underwent 
validation and consistency checks to identify and resolve 
errors before they were merged using the HDSS unique 
identifiers or sample codes as appropriate.
Using the MCA model, households were characterized 
into five socio-economic quintiles with the first quin-
tile as the poorest and the fifth quintile as the least-poor 
based on household assets, utilities and occupation [20, 
22]. A generalized linear model, customized with a log-
link function, was used to estimate and compare adjusted 
prevalence ratios (aPR). Dependent variables included 
malaria infection, care seeking, medication and ITN use, 
while SES, study areas (i.e., sub-counties), sex and age 
groups (< 5, 5–14 and ≥ 15 years) were included as inde-
pendent variables. As described in detail elsewhere, SES 
quintiles were aggregated into dichotomous groups [9]. 
A binary variable was created with the first three SES 
quintiles (i.e., poorest, second and third poorest) grouped 
as the ‘poorest’ category and the fourth and fifth quin-
tiles grouped into the ‘less-poor’ category, with the lat-
ter as the reference category in the models. Proportions 
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and 95% confidence intervals were generated, and p val-
ues < 0.05 were considered statistically significant. Pro-
portions were compared using Fisher’s exact test, and the 
price of medications were compared using a generalized 
linear model. Medians and interquartile ranges were gen-
erated if data were not normally distributed; medication 
expenditures were compared using Wilcoxon rank-sum 
test because price data were not normally distributed.
Ethics, consent and permissions
The HDSS protocol and consent procedures, including 
surveillance, were approved by KEMRI (SSC#1801) and 
CDC (#3308) institutional review boards (IRB) annu-
ally. The malaria-specific survey, including collection of 
blood samples, received approval from the KEMRI scien-
tific steering committee (#2031) and CDC IRB (#6012). 
Written consent was obtained in the local language prior 
to administration of the questionnaires.
Results
Characteristics of study participants
A total of 1063 households and 2719 individuals were 
surveyed in July 2012, approximately 1 year after a mass 
ITN distribution in the study area. Participants ages were 
categorized into < 5 years (56.8%; n = 1545), 5–14 (17.4%; 
n = 437), and ≥ 15 years (25.8%; n = 701) (Table 1).
Descriptive epidemiology
The prevalence of malaria parasitaemia by microscopy 
was 34.1% overall, 34.4% among children < 5 years, 54.8% 
in 5–14  year olds and 19.3% in persons aged ≥ 15  years 
(Table 2). Fever in the 14 days prior to the survey was self-
reported by 53.9% (n = 1463) of the survey population; 
this was highest (60.6%) among children aged < 5  years 
(Table 2). Of those reporting fever, 70.4% (n = 1032) had 
sought care. Of those who sought care, 51.8% sought care 
from health facilities, 30.4% from pharmacies, and 15.4% 
from shops. Use of any medication among those who 
reported having fever was 77.3% overall, with the high-
est proportion among young children (81.9%), and lowest 
(65.2%) among persons aged ≥ 15 years. Overall, 64.9% of 
the population reported ITN use the night prior to the 
survey (Table 2).
Multivariable analysis
Overall, 37.6% of persons from the poorest house-
holds had malaria infection compared to 29.2% of per-
sons from less-poor households (adjusted prevalence 
ratio [aPR] = 1.23; 95% CI = 1.08–1.41, p = 0.002), when 
adjusting for age, geographic area, gender and ITN 
use (Table  3). In multivariate analysis of care seeking 
(n = 1182), children < 5  years were significantly more 
likely to seek care (aPR = 1.27; 95% CI = 1.14–1.41, 
p < 0.001) compared to adults ≥ 15  years. There were 
no significant differences in care seeking by SES, gen-
der or geographic area (Table  4). Among persons who 
Table 1 Sociodemographic characteristics of  study popu-
lation in Siaya County, Kenya, 2012
a n = 2719 total population surveyed
Categories na Percent
Age groups (years)
 < 5 1545 56.8
 5–14 437 17.4
  ≥ 15 701 25.8
Sex
 Female 1494 54.9
 Male 1225 45.1
Wealth quintiles (SES)
 1 (Poorest) 458 20.6
 2 434 19.5
 3 459 20.6
 4 436 19.6
 5 (Least poor) 441 19.8
Sub‑counties
 Rarieda 834 30.7
 Gem 872 32.0
 Siaya 1013 37.3
Table 2 Descriptive epidemiology of malaria-related indicators in Siaya County, Kenya, 2012
ITN insecticide-treated net
a Self-reported fever
b Of 1463 persons who reported having fever, 1131 took medication
< 5 years n (%) 5–14 years n (%) ≥ 15 years n (%) Total n (%)
Fever in prior 2 weeksa 935 (60.6) 209 (44.2) 319 (45.5) 1463 (53.9)
Malaria parasitaemia 532 (34.4) 259 (54.8) 135 (19.3) 926 (34.1)
Care seeking 708 (75.6) 134 (64.1) 190 (59.6) 1032 (70.4)
Medication  usageb 766 (81.9) 157 (75.1) 208 (65.2) 1131 (77.3)
ITN use 1033 (66.9) 251 (53.1) 481 (68.6) 1765 (64.9)
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reported fever in the prior 14 days, prevalence of medi-
cation use was significantly higher in children < 5  years 
(aPR = 1.27; 95% CI = 1.15–1.40, p < 0.001) compared 
to adults ≥ 15  years. The poorest persons reported less 
medication use, but it was not significantly different 
compared to the less-poor (aPR 0.94, 95% CI = 0.88–1.0; 
p = 0.05) (Table 4).
Ownership of at least one ITN per household over-
all was very high at 93.9%; ITN ownership was not dif-
ferent between the poorest and less-poor households 
Table 3 Multivariate analysis of socioeconomic status and association with malaria infection in Siaya, Kenya, 2012
ITN insecticide-treated net, SES socioeconomic status
a ‘Poorest’ was constituted by collapsing the poorest three quintiles
b ‘Less-poor’ was constituted by collapsing the wealthiest two quintiles
Characteristic n N Malaria parasitaemia percent Adjusted prevalence ratio 95% confidence 
interval
p value
Overall 926 2228 34.1
SES
 Pooresta 401 1070 37.5 1.23 1.08 1.41 0.002
 Less  poorb 338 1158 29.2 Ref
Age group (years)
  < 5 395 1177 33.6 1.76 1.46 2.14 < 0.001
 5–14 227 427 53.2 2.74 2.27 3.31 < 0.001
  ≥ 15 117 624 18.8 Ref
Sub‑county
 Gem 278 278 278 1.38 1.14 1.65 0.001
 Siaya 278 842 31.8 1.12 0.93 1.35 0.241
 Rarieda 193 701 27.5 Ref
ITN usage
 Yes 429 1449 29.6 0.84 0.73 0.96 0.010
 No 29.6 779 39.8 Ref
Table 4 Association of socioeconomic status with care-seeking and medication usage in Siaya County, Kenya, 2012
SES socioeconomic status, aPR adjusted prevalence ratio, CI confidence interval
a Among the surveyed population who self-reported fever in the prior 2 weeks
Care seeking (n = 1182)a Medication use (n = 1180)a
n N % aPR 95% CI p value n N % aPR 95% CI p value
SES
 Poorest 411 598 68.7 0.95 0.87 1.04 0.229 447 598 74.8 0.94 0.87 1.00 0.087
 Less‑poor 414 584 70.9 Ref 457 582 78.5 Ref
Age group (years)
  < 5 535 716 74.7 1.27 1.14 1.40 < 0.001 582 714 81.5 1.27 1.15 1.40 < 0.001
 5–14 124 188 66.0 1.11 0.97 1.29 0.120 142 188 75.5 1.17 1.04 1.32 0.008
  ≥ 15 166 278 59.7 Ref 180 278 64.8 Ref
Sub‑county
 Gem 301 407 74.0 1.05 0.94 1.17 0.391 326 406 80.3 1.10 1.01 1.20 0.037
 Siaya 301 459 66.8 0.91 0.82 1.02 0.110 347 458 75.8 1.02 0.94 1.10 0.657
 Rarieda 223 316 70.6 Ref 231 216 73.1 Ref
Sex
 Female 460 656 70.1 1.03 0.96 1.11 0.350 500 655 76.3 1.02 0.95 1.08 0.617
 Male 365 526 69.4 Ref 404 525 77.0 Ref
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(93.5% versus 94.3, p = 0.72) (Table  5). The use of ITNs 
was also common; overall, 65.0% of persons reported 
using nets the night before the survey. In multivari-
ate analysis of association between SES and ITN usage, 
63.2% of persons in the poorest group used ITNs com-
pared with 66.8% amongst the less-poor, but the differ-
ence was not statistically significant (aPR = 0.96; 95% 
CI = 0.90–1.02, p = 0.18). Significant differences were 
observed in reported ITN use by sub-county, with a sig-
nificantly higher proportion of persons from Rarieda 
(80.5%) using ITNs compared to Gem (56.5%) or Siaya 
(59.1%) (p < 0.001 for both).
Of the 1180 individuals with reported history of fever 
in the 14 days prior to the survey who had malaria infec-
tion and had SES data available, 34.5% (n = 505) took the 
recommended first-line malaria medication, artemether-
lumefantrine (AL) (Table 6). Among those who took AL, 
30.9% were from the poorest households compared to 
36.2% from less-poor households (p = 0.43). Amongst 
individuals who used any malaria medicines, use of 
non-recommended medicines was 4.9% in the poor-
est households compared to 3.5% in less-poor house-
holds (p = 0.32). The expenditure on any type of malaria 
medications in the 14  days prior to survey was not sta-
tistically different between the poorest and less-poor 
household members (mean US$0.35, standard deviation 
[30] US$0.52 versus mean US$0.40 [US$0.55]; p = 0.076, 
respectively). However, persons in the poorest house-
holds spent significantly more purchasing non-recom-
mended malaria medicines compared to persons from 
less-poor households (mean = US$1.36 [US$0.91] versus 
mean US$0.98 [US$0.80]; p = 0.039).
Discussion
The study evaluated the relationship between burden of 
malaria infection and household SES within an area of 
rural western Kenya. This is the first published paper to 
assess the relationship between malaria indicators and 
SES using the MCA model to generate household wealth 
quintiles based on continuous and categorical variables. 
The findings show that individuals in the poorest house-
holds had a higher burden of malaria infection compared 
to those from less-poor households. Persons from the 
poorest households also spent significantly more money 
to purchase medications that are not recommended for 
malaria treatment, which are likely to have less clinical 
efficacy and lead to unnecessary risk of adverse effects 
and complications of taking inappropriate medications. 
No significant associations between care seeking and 
SES or medication use and SES were observed, and the 
study found high access to and use of ITNs, irrespec-
tive of household SES. Prevalence of malaria infection 
was significantly higher in Gem sub-county compared to 
Rarieda sub-county. This could be due to high vegetation 
coverage and the presence of River Yala which cuts across 
the sub-county. These findings contribute to the scarce 
published literature on malaria and socioeconomic ine-
qualities. Although there is extensive literature on health 
inequalities and health outcomes more generally, no 
previous study has evaluated the relationships between 
malaria indicators and SES using MCA to analyse micro-
economic data.
The study results are similar to findings by Somi and 
colleagues who reported a large variation in parasitaemia 
rates between socioeconomic groups, where individuals 
Table 5 Association between  household socioeconomic status and  insecticide-treated net use in  Siaya County, Kenya, 
2012
SES socioeconomic status, ITN insecticide-treated net, aPR adjusted prevalence ratio
n N ITN use percent aPR 95% confidenceinterval p-value
SES
 Poorest 676 1070 63.2 0.96 0.87 1.05 0.397
 Less‑poor 773 1158 66.8 Ref
Age group (years)
  < 5 790 1117 67.1 1.00 0.94 1.07 0.976
 5‑14 231 427 54.1 0.79 0.71 0.89 < 0.001
  ≥ 15 428 624 68.6 Ref
Sub‑county
 Gem 387 685 56.5 0.70 0.63 0.79 < 0.001
 Siaya 498 842 59.1 0.73 0.65 0.81 < 0.001
 Rarieda 564 701 80.5 Ref
Sex
 Female 802 1225 65.5 1.00 0.95 1.07 0.811
 Male 647 1003 64.5 Ref
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with the lowest SES were significantly more likely to have 
malaria parasites than less-poor individuals [8]. Find-
ings from this analysis, however, contrast with those of 
de Castro and Fisher who found that SES had no asso-
ciation with malaria infection [6]. The de Castro study, 
however, was limited to children aged 6–59  months 
whereas a study by Somi et al. in which the analysis was 
not restricted to a specific age group [5, 8]. Both cross-
sectional studies used household assets and proxies to 
measure SES using the PCA model [6, 10, 19]. This study 
addressed some of the limitations of these previous stud-
ies by using malaria confirmed by microscopy, as the 
main outcome of interest controlling for age group, and 
using generalized linear models instead of traditional 
concentration indices and Lorenz curves to estimate the 
risk of health indicators as a measure of inequity as rec-
ommended by World Bank and World Health Organiza-
tion [13, 17, 19].
Previous studies on health outcomes, including 
malaria, and SES have traditionally used the PCA model 
to generate a household SES index. The PCA model 
relies heavily on dichotomous socioeconomic vari-
ables to achieve a composite household SES index [14, 
15, 19]. Benefits of using the MCA model are inclusion 
of both continuous and categorical variables and larger 
weights for assets, which increases statistical power [21, 
22]. Using PCA models to generate household SES indi-
ces was anticipated to facilitate a more robust evidence 
base for assessing the associations between health out-
comes and poverty, especially at the household and com-
munity levels [14, 15, 19, 21]. However, recent literature 
has demonstrated the weaknesses of PCA models includ-
ing the inability to accommodate continuous variables 
such as number of assets owned and generation of low 
asset weights, which makes it difficult to determine clear 
wealth quintile cut-offs particularly in settings where 
most households have the same assets and therefore the 
same or very similar SES scores [21, 22]. Based on evi-
dence already published [20] that MCA is a better model 
than PCA, this study has applied MCA for assessment 
of socioeconomic status to assess malaria related health 
inequalities.
The study determined that nearly two-thirds of persons 
had fever in the past 2 weeks, and the majority (81%) of 
them took medication with an equal proportion of indi-
viduals among the poorest and less-poor households. 
Nearly half of those who sought care went to health facil-
ities, but the other half sought care from pharmacies and 
Table 6 Use of  and expenditure on  malaria medication in  surveyed population who reported fever in  prior 2  weeks 
in Siaya County, Kenya, 2012
USD United States dollars, SD standard deviation, IQR interquartile range
a Non-recommended medicine for malaria treatment included sulfadoxine-pyrimethamine, amodiaquine, quinine used by non-pregnant women and chloroquine
b Mean prices of adult formulation were artemether-lumefantrine = USD 1.01; sulfadoxine-pyrimethamine = USD 0.62; amodiaquine = USD 0.42; quinine = USD 2.24; 
chloroquine = USD 0.40
c Fisher’s exact test
d Wilcoxon rank sum test to compare medians and t-test to compare means; excludes children who received medicine for free from public health facilities
Utilization of medication (N = 1180) All Poorest households Less-poor households
n (%) n (%) n (%) p-valuec
Artemether‑lumefantrine 396 (33.6) 185 (30.9) 211 (36.2) 0.434
Sulphadoxine‑pyrimethamine 8 (0.7) 6 (1.0) 2 (0.3) 0.119
Amodiaquine 11 (0.9) 7 (1.2) 4 (0.7) 0.284
Quinine 14 (1.2) 6 (1.0) 8 (1.4) 0.721
Chloroquine 5 (0.4) 3 (0.3) 2 (0.3) 0.557
Overall (any malaria medicine) 429 (36.4) 205 (34.3) 224 (38.4) 0.133
Non‑recommended  medicinea 38 (4.2) 22 (4.9) 16 (3.5) 0.332
Mean (SD) in USD Mean (SD) in USD Mean (SD) in USD
Expenditure on all malaria medications per person 0.38 (0.50) 0.35 (0.52) 0. 40 (0.55) 0.076
Mean (SD)
Median (IQR)
in USD
Mean (SD)
Median (IQR)
in USD
Mean (SD)
Median (IQR)
in USD
p-valued
Expenditure on all medications per person among only those 
who paid for drugs (n = 424)b
1.04 (0.32)
1.01 (1.01–1.01)
1.02 (0.32)
1.01 (1.01–1.01)
1.05 (0.33)
1.01 (1.01–1.01)
0.345
0.926
Expenditure on non‑recommended malaria medicines per 
person (n = 38)
1.14 (0.86)
0.62 (0.42–2.24)
1.36 (0.91)
1.43 (0.45–2.24)
0.98 (0.80)
0.62 (0.42–2.24)
0.039
0.018
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informal drug shops. Research from Kenya shows that 
people who seek care from health facilities are more likely 
to get tested for malaria and receive the first-line recom-
mended medications for treatment compared to those 
who go to pharmacies and informal drug shops [29, 31–
33]. There were no differences observed in the expendi-
ture on all malaria medications per person between SES 
groups, and less than 5% of persons purchased non-rec-
ommended malaria medicines overall, which is a positive 
finding. However, the poorest households spent more 
to purchase potentially ineffective medicines compared 
to less-poor households; ineffective treatments poten-
tially prolong parasitaemia or fail to clear parasitaemia, 
which can lead to recrudescence or severe malaria and 
increased expenditures on additional treatments or hos-
pitalizations. The findings of this study suggests a need to 
encourage healthcare seeking in the formal health sector, 
especially among the poorest households.
No significant differences in ITN ownership or usage 
between the poorest and less-poor households was 
observed in this rural western Kenya community in 2012, 
which was less than a year after the first universal cov-
erage ITN distribution in Siaya County. Ownership of 
at least one ITN per household overall reached near full 
coverage (94%) and was well above the national target of 
80% [34]. Subsequent national household surveys have 
consistently demonstrated significant differences in ITN 
ownership, access and use between the lowest and high-
est wealth quintiles [4, 26]. Because this cross-sectional 
study was conducted in a relatively small geographic area 
(i.e., three sub-counties) of rural Siaya County, there is 
probably much less socioeconomic variation compared 
to the national population and more uniformity in pro-
grammatic distribution within a single county.
A key principle of the Kenya Health Policy 2014–2030 
is to achieve equity in the distribution of health services 
and interventions by 2030 [35]. Findings from this study 
illustrate existing socioeconomic inequalities in the 
burden of malaria infection and expenditures on non-
recommended malaria medication in this rural western 
Kenya setting. However, the lack of differences between 
SES groups in care seeking, overall medication use and 
expenditures, and ITN ownership and use demonstrate 
the progress toward achieving equitable access to health 
services and distribution of free malaria commodities, 
including first-line medicines for treatment and ITNs, 
in western Kenya. Analysis of malaria indicators in rela-
tion to household SES using MCA methodology can be 
used to monitor progress towards achieving health equity 
goals in line with the Kenya Health Policy 2014–2030 and 
global sustainable development goals [36].
The study has a number of limitations. Findings were 
based on one cross-sectional survey preventing any 
evaluation of cause-and-effect of SES on malaria indi-
cators over time. A longitudinal or trend analysis of 
repeated surveys would have provided an opportunity 
to study changes in SES and monitor the gap in malaria 
indicators between the poorest and less-poor households 
over time as malaria control interventions, including free 
first-line malaria treatment at health facilities and ITNs, 
were implemented. The other limitation was inclusion of 
only households with children < 5  years of age based on 
protocol-specific objectives. While this study advances 
the knowledge related to the association between 
malaria, control interventions and microeconomics, 
under these limitations, it reduces generalizability. Addi-
tionally, expenditures were calculated per person rather 
than per household because not all persons in the house-
hold were interviewed or tested for malaria. Although 
all children < 5  years of age were surveyed, only a small 
proportion of persons ≥ 5  years of age were included in 
the survey sample. Finally, the use of assets as proxies 
for SES also has limitations including, most importantly, 
that the monetary value of assets was not collected, and 
hence the net worth of the household might be over- or 
under-estimated. Asset-based proxies, however, have 
been shown as a reasonable way to measure wealth status 
in the absence of household income or expenditure data, 
which is not commonly available in informal economies 
[30]. This study did not compare the current results with 
any other results which could have been analysed using 
other methods besides MCA because there is already evi-
dence that MCA is better model than PCA. Such com-
parison would not be statistically different in assigning 
households into the quintiles [20].
Conclusion
In rural western Kenya, individuals in the poorest house-
holds had a higher burden of malaria prevalence com-
pared to those from less-poor households. However, no 
significant differences were observed in care seeking, 
overall medication use and expenditure, or ITN own-
ership and use between households based on SES. This 
study demonstrates that the MCA model can be a use-
ful tool for assessing malaria-related health inequali-
ties at the microeconomic level and to monitor progress 
towards achieving equitable access to health services and 
distribution of malaria interventions in line with national 
and global health and development goals.
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